COVID-19

News

Gilead's remdesivir hailed as COVID-19 standard of care afte...

It's official - Gilead's remdesivir helps severely ill patients recover faster from COVID-19, according to results from a phase 3 placebo-controlled trial.

Partner Content

Partner Content

New collaboration launched to drive understanding of COVID-1...

Medicines Discovery Catapult, Retrogenix and Peak Proteins collaborate to identify target receptors for COVID-19

News

UK initiative aims to cut COVID-19 drug development to a few...

A new UK trial initiative aims to cut the design phase of clinical studies for potential COVID-19 drugs from around 18 months to a few weeks.

News

AZ maintains 2020 guidance as Q1 sales grow despite pandemic

The ongoing pandemic will not affect AstraZeneca’s performance in 2020, the company has said after its first quarter results beat analysts’ expectations.

Views & Analysis

Maintaining patient access to care during COVID-19

COVID-19 casts a spotlight on the need for healthcare providers to interact with people virtually, address the affordability crisis compounded by the pandemic, and alleviate the challenges

News

COVID-19 to hurt 2020 revenues, says Merck & Co

Merck & Co has lowered its full-year revenue and earnings estimates because of the impact of COVID-19 on its business, which is focused on products administered in hospitals. <

Gilead's remdesivir hailed as COVID-19 standard of care afte...

New collaboration launched to drive understanding of COVID-1...

UK initiative aims to cut COVID-19 drug development to a few...

AZ maintains 2020 guidance as Q1 sales grow despite pandemic

Maintaining patient access to care during COVID-19

COVID-19 to hurt 2020 revenues, says Merck & Co

Lilly bags FDA okay for Wegovy pill rival orforglipron

Using AI-driven synthetic personas to take your insights fur...

COVID-19

Editor's Picks